Stay updated with breaking news from Data Expected. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...
Topline Data Expected in 2023ROSWELL, Ga. and DUBLIN and HAMILTON, Bermuda, May 3, 2022 /PRNewswire/ -- Saol Therapeutics, a privately held, clini...
Verona Pharma Completes Enrollment in Phase 3 ENHANCE-2 Trial Evaluating Ensifentrine for Maintenance Treatment of COPDTop-line Data Expected in the Third Quarter of 2022 LONDON and RALEIGH, N.C., January 24, 2022 – Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”...